Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
SK
Mahil
;
ZZN
Yiu
;
KJ
Mason
;
N
Dand
;
B
Coker
;
D
Wall
;
G
Fletcher
;
A
Bosma
;
F
Capon
;
L
Iversen
;
+13 more...
SM
Langan
;
P
Di Meglio
;
AH
Musters
;
D
Prieto-Merino
;
T
Tsakok
;
RB
Warren
;
C
Flohr
;
PI
Spuls
;
CEM
Griffiths
;
J
Barker
;
AD
Irvine
;
CH
Smith
;
Secure-AD and PsoProtect study groups
;
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.
Item Type | Article |
---|---|
Elements ID | 147445 |
Date Deposited | 07 May 2020 12:03 |
ORCID: https://orcid.org/0000-0003-4913-1522
ORCID: https://orcid.org/0000-0002-1831-074X
ORCID: https://orcid.org/0000-0002-5419-0669
ORCID: https://orcid.org/0000-0003-2432-5793
ORCID: https://orcid.org/0000-0003-1816-4508
ORCID: https://orcid.org/0000-0002-7022-7441
ORCID: https://orcid.org/0000-0001-5001-0061
ORCID: https://orcid.org/0000-0003-4884-6286
ORCID: https://orcid.org/0000-0002-9048-2044